Cover Image
市場調查報告書

勃奇氏淋巴瘤:全球臨床實驗趨勢

Burkitt Lymphoma Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 361073
出版日期 內容資訊 英文 268 Pages
訂單完成後即時交付
價格
Back to Top
勃奇氏淋巴瘤:全球臨床實驗趨勢 Burkitt Lymphoma Global Clinical Trials Review, H1, 2017
出版日期: 2017年05月31日 內容資訊: 英文 268 Pages
簡介

本報告提供勃奇氏淋巴瘤的治療藥相關臨床實驗趨勢,提供您調查分析,主要7個市場 (G7) 及新興7市場 (E7) 的臨床實驗數和進展,受驗人數,各階段及各期狀況,並彙整有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等資料。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上勃奇氏淋巴瘤的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上勃奇氏淋巴瘤的比例

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

勃奇氏淋巴瘤治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Burkitt Lymphoma Global Clinical Trials Review, H1, 2017" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Burkitt Lymphoma to Oncology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Burkitt Lymphoma to Oncology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Burkitt Lymphoma Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 265

  • Abbreviations 265
  • Definitions 265
  • Research Methodology 266
  • Secondary Research 266
  • About GlobalData 267
  • Contact Us 267
  • Disclaimer 267
  • Source 268

List of Tables

List of Tables

  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Burkitt Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Burkitt Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Burkitt Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Burkitt Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Burkitt Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Burkitt Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Burkitt Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Burkitt Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017* 17
  • Burkitt Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Burkitt Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Burkitt Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Burkitt Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Burkitt Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Burkitt Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Proportion of Burkitt Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Burkitt Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Burkitt Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Burkitt Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017* 17
  • Burkitt Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Burkitt Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
  • Burkitt Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Burkitt Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 266
Back to Top